UROLOGIC NEOPLASMS
Clinical trials for UROLOGIC NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new UROLOGIC NEOPLASMS trials appear
Sign up with your email to follow new studies for UROLOGIC NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for rare penile cancer
Disease control Recruiting nowThis study tests a combination of chemotherapy (carboplatin and paclitaxel) plus an immunotherapy drug (pembrolizumab) in 27 men with advanced penile cancer that has spread to lymph nodes. The goal is to see if this treatment can completely eliminate the cancer before surgery. Pa…
Matched conditions: UROLOGIC NEOPLASMS
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 17, 2026 03:14 UTC
-
Could a dual immunotherapy spare the bladder in cancer patients?
Disease control Recruiting nowThis study tests whether giving two immunotherapy drugs (nivolumab with or without relatlimab) before surgery can eliminate bladder cancer completely, allowing some patients to avoid bladder removal. About 90 adults with stage II-IIIa bladder cancer will receive the drugs and the…
Matched conditions: UROLOGIC NEOPLASMS
Phase: PHASE2 • Sponsor: The Netherlands Cancer Institute • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for kidney cancer: vorolanib under the microscope
Disease control Recruiting nowThis study looks at how well the drug vorolanib works for people with advanced kidney cancer that has spread or cannot be removed by surgery. It is for patients who need a second treatment after the first one stopped working. Researchers will track how long patients live without …
Matched conditions: UROLOGIC NEOPLASMS
Sponsor: Jinling Hospital, China • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
New scan could spot kidney cancer more accurately
Diagnosis Recruiting nowThis study aims to see if a new imaging agent called [18F]RCCB6 can improve the detection of kidney cancer, especially the most common type (clear cell renal cell carcinoma). Researchers will enroll 300 adults with confirmed or suspected kidney cancer to measure how well the trac…
Matched conditions: UROLOGIC NEOPLASMS
Phase: PHASE2 • Sponsor: RenJi Hospital • Aim: Diagnosis
Last updated Apr 30, 2026 15:52 UTC
-
Skin test may predict dangerous blood pressure drops in elderly cancer surgery
Knowledge-focused Recruiting nowThis study looks at whether measuring skin conductance (a sign of nerve activity) can help predict sudden drops in blood pressure after spinal anesthesia in older adults with cancer. About 100 patients aged 65 and older having urologic cancer surgery will be monitored. The goal i…
Matched conditions: UROLOGIC NEOPLASMS
Sponsor: Dr Abdurrahman Yurtaslan Ankara Oncology Training and Research Hospital • Aim: Knowledge-focused
Last updated May 17, 2026 03:10 UTC